About PerSapien
PerSapien is a company based in Delhi (India) founded in 2017. PerSapien has raised $164.82 thousand across 2 funding rounds from investors including GAIL. PerSapien offers products and services including Airlens, Minus Corona, and Minus 2.5. PerSapien operates in a competitive market with competitors including VitalFlo, Resmonics, Inofab Health, My mHealth and AsthmaMD, among others.
- Headquarter Delhi, India
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Persapien Innovations Private Limited
- Date of Incorporation 19 Jul, 2017
- Jurisdiction South West Delhi, Delhi, India
-
Annual Revenue
$128.29 K (USD)12.92as on Mar 31, 2020
-
Net Profit
-$73.29 K (USD)-10799.63as on Mar 31, 2020
-
EBITDA
-$86.05 K (USD)-15798.35as on Mar 31, 2020
-
Total Equity Funding
$164.82 K (USD)
in 2 rounds
-
Latest Funding Round
$164.82 K (USD), Seed
Nov 06, 2018
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PerSapien
PerSapien offers a comprehensive portfolio of products and services, including Airlens, Minus Corona, and Minus 2.5.
Device that tackles airborne pandemics and pollution effectively.
Invention designed to combat viral airborne threats simply.
Technology for reducing fine particle pollution in air.
Funding Insights of PerSapien
PerSapien has successfully raised a total of $164.82K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $164.82 thousand completed in November 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in PerSapien
PerSapien has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include GAIL.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Natural gas exploration, production, transmission, marketing, and processing are conducted.
|
Locked | Locked | Locked |
Investor details for PerSapien
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PerSapien
Investment portfolio details for PerSapien
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PerSapien
Detailed financials for PerSapien
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Persapien Comparisons
Peer comparison for PerSapien
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PerSapien
PerSapien operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as VitalFlo, Resmonics, Inofab Health, My mHealth and AsthmaMD, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
App for managing asthma through clinical insights
|
|
| Locked | Locked | Locked |
AI-based system for monitoring respiratory diseases is provided.
|
|
| Locked | Locked | Locked |
Spirometer applications for respiratory health monitoring are developed.
|
|
| Locked | Locked | Locked |
Chronic conditions are managed via an online patient platform.
|
|
| Locked | Locked | Locked |
AsthmaMD is focused on asthma management through mobile technology.
|
Detailed competitors of PerSapien
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Persapien
Complete news archive for PerSapien
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PerSapien
PerSapien was founded in 2017 and raised its 1st funding round 1 year after it was founded.
PerSapien is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
PerSapien is a funded company, having raised a total of $164.82K across 2 funding rounds to date.
Annual revenue of PerSapien is $128.29K as on Mar 31, 2020.
PerSapien has developed a nasal purifier and an app for managing lung or respiratory health from air pollution. The company has developed Airlens, a nasal purifier connected Airlens Data AQI(Air Quality index) app for tracking the AQI at the location in real-time, track daily activities and monitor the pollution. The app suggests the usage of the Airlens nasal purifier based on the health risks and pollution levels.
PerSapien's top competitors include VitalFlo, Resmonics and My mHealth.
PerSapien offers Airlens, Minus Corona, and Minus 2.5.
PerSapien has 1 investor. Key investors include GAIL.
The valuation of PerSapien is $5.58M as of Nov 2018.